• 2021
  Cunha MDP, Vilela APP, Molina CV, Acuña SM, Muxel SM, Barroso VM, Baroni S, Gomes de Oliveira L, Angelo YS, Peron JPS, Góes LGB, Campos ACA, Minóprio P, , Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic Patient., Front Med (Lausanne) 2021 ; 8(): 760170.
• 2015
  Jackson AP, Goyard S, Xia D, Foth BJ, Sanders M, Wastling JM, Minoprio P, Berriman M, Global Gene Expression Profiling through the Complete Life Cycle of Trypanosoma vivax, PLoS Negl Trop Dis 2015 Aug;9(8):e0003975.
• 2015
  Caballero ZC, Costa-Martins AG, Ferreira RC, P Alves JM, Serrano MG, Camargo EP, Buck GA, Minoprio P, G Teixeira MM, Phylogenetic and syntenic data support a single horizontal transference to a Trypanosoma ancestor of a prokaryotic proline racemase implicated in parasite evasion from host defences, Parasit Vectors 2015;8:222.
• 2013
  Goyard S, Dutra PL, Deolindo P, Autheman D, D'Archivio S, Minoprio P, In vivo imaging of trypanosomes for a better assessment of host-parasite relationships and drug efficacy, Parasitol. Int. 2014 Feb;63(1):260-8.
• 2013
  Berneman A, Montout L, Goyard S, Chamond N, Cosson A, d'Archivio S, Gouault N, Uriac P, Blondel A, Minoprio P, Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas’ disease, PLoS ONE 2013;8(4):e60955.
• 2013
  D'Archivio S, Cosson A, Medina M, Lang T, Minoprio P, Goyard S, Non-invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infections, PLoS Negl Trop Dis 2013;7(1):e1976.
• 2011
  D'Archivio S, Medina M, Cosson A, Chamond N, Rotureau B, Minoprio P, Goyard S, Genetic engineering of Trypanosoma (Dutonella) vivax and in vitro differentiation under axenic conditions, PLoS Negl Trop Dis 2011 Dec;5(12):e1461.
• 2011
  Conti P, Tamborini L, Pinto A, Blondel A, Minoprio P, Mozzarelli A, De Micheli C, Drug discovery targeting amino acid racemases, Chem. Rev. 2011 Nov;111(11):6919-46.
• 2010
  Blom-Potar MC, Chamond N, Cosson A, Jouvion G, Droin-Bergère S, Huerre M, Minoprio P, Trypanosoma vivax infections: pushing ahead with mouse models for the study of Nagana. II. Immunobiological dysfunctions, PLoS Negl Trop Dis 2010;4(8).
• 2010
  Chamond N, Cosson A, Blom-Potar MC, Jouvion G, D'Archivio S, Medina M, Droin-Bergère S, Huerre M, Goyard S, Minoprio P, Trypanosoma vivax infections: pushing ahead with mouse models for the study of Nagana. I. Parasitological, hematological and pathological parameters, PLoS Negl Trop Dis 2010;4(8):e792.
• 2010
  Olivieri BP, Vasconcellos R, Nóbrega A, Minoprio P, Kaveri SV, Araújo-Jorge TC, Intravenous immunoglobulin increases survival time in the acute phase of experimental Chagas disease, Parasite Immunol. 2010 Jun;32(6):464-9.
• 2009
  Coutinho L, Ferreira MA, Cosson A, Batista MM, Batista Dda G, Minoprio P, Degrave WM, Berneman A, Soeiro Mde N, Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection, Mem. Inst. Oswaldo Cruz 2009 Dec;104(8):1055-62.
• 2009
  Coutinho L, Ferreira MA, Cosson A, Batista MM, Batista Dda G, Minoprio P, Degrave WM, Berneman A, Soeiro Mde N, Inhibition of Trypanosoma cruzi proline racemase affects host-parasite interactions and the outcome of in vitro infection, Mem. Inst. Oswaldo Cruz 2009 Dec;104(8):1055-62.
• 2009
  Coatnoan N, Berneman A, Chamond N, Minoprio P, Proline racemases: insights into Trypanosoma cruzi peptides containing D-proline, Mem. Inst. Oswaldo Cruz 2009 Jul;104 Suppl 1:295-300.
• 2009
  Chamond N, Cosson A, Coatnoan N, Minoprio P, Proline racemases are conserved mitogens: characterization of a Trypanosoma vivax proline racemase, Mol. Biochem. Parasitol. 2009 Jun;165(2):170-9.
• 2007
  Goytia M, Chamond N, Cosson A, Coatnoan N, Hermant D, Berneman A, Minoprio P, Molecular and structural discrimination of proline racemase and hydroxyproline-2-epimerase from nosocomial and bacterial pathogens, PLoS ONE 2007;2(9):e885.
• 2006
  Buschiazzo A, Goytia M, Schaeffer F, Degrave W, Shepard W, Grégoire C, Chamond N, Cosson A, Berneman A, Coatnoan N, Alzari PM, Minoprio P, Crystal structure, catalytic mechanism, and mitogenic properties of Trypanosoma cruzi proline racemase, Proc. Natl. Acad. Sci. U.S.A. 2006 Feb;103(6):1705-10.
• 2005
  Chamond N, Goytia M, Coatnoan N, Barale JC, Cosson A, Degrave WM, Minoprio P, Trypanosoma cruzi proline racemases are involved in parasite differentiation and infectivity, Mol. Microbiol. 2005 Oct;58(1):46-60.
• 2003
  Chamond N, Grégoire C, Coatnoan N, Rougeot C, Freitas-Junior LH, da Silveira JF, Degrave WM, Minoprio P, Biochemical characterization of proline racemases from the human protozoan parasite Trypanosoma cruzi and definition of putative protein signatures, J. Biol. Chem. 2003 May;278(18):15484-94.
• 2002
  Chamond N, Coatnoan N, Minoprio P, Immunotherapy of Trypanosoma cruzi infections, Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002 Oct;2(3):247-54.
• 2002
  Waghabi MC, Coutinho CM, Soeiro MN, Pereira MC, Feige JJ, Keramidas M, Cosson A, Minoprio P, Van Leuven F, Araújo-Jorge TC, Increased Trypanosoma cruzi invasion and heart fibrosis associated with high transforming growth factor beta levels in mice deficient in alpha(2)-macroglobulin, Infect. Immun. 2002 Sep;70(9):5115-23.
• 2001
  Minoprio P, Parasite polyclonal activators: new targets for vaccination approaches?, Int. J. Parasitol. 2001 May;31(5-6):588-91.
• 2001
  Santos-Lima EC, Vasconcellos R, Reina-San-Martín B, Fesel C, Cordeiro-Da-Silva A, Berneman A, Cosson A, Coutinho A, Minoprio P, Significant association between the skewed natural antibody repertoire of Xid mice and resistance to Trypanosoma cruzi infection, Eur. J. Immunol. 2001 Feb;31(2):634-45.
• 2000
  Reina-San-Martín B, Degrave W, Rougeot C, Cosson A, Chamond N, Cordeiro-Da-Silva A, Arala-Chaves M, Coutinho A, Minoprio P, A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase, Nat. Med. 2000 Aug;6(8):890-7.
• 2000
  Reina-San-Martin B, Cosson A, Minoprio P, Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents, Parasitol. Today (Regul. Ed.) 2000 Feb;16(2):62-7.
• 2000
  Sato MN, Minoprio P, Avrameas S, Ternynck T, Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms, Clin. Exp. Immunol. 2000 Feb;119(2):333-9.
• 1999
  Moreau MF, Thibaud JL, Miled LB, Chaussepied M, Baumgartner M, Davis WC, Minoprio P, Langsley G, Theileria annulata in CD5(+) macrophages and B1 B cells, Infect. Immun. 1999 Dec;67(12):6678-82.
• 1999
  Montes CL, Zuñiga E, Minoprio P, Vottero-Cima E, Gruppi A, A Trypanosoma cruzi alkaline antigen induces polyclonal B-cell activation of normal murine spleen cells by T-cell-independent, BCR-directed stimulation, Scand. J. Immunol. 1999 Aug;50(2):159-66.
• 1999
  Gomes YM, Abath FG, Nakazawa M, Minoprio P, Vouldoukis I, Monjour L, Partial protection of mice against Trypanosoma cruzi after immunizing with the TcY 72 antigenic preparation, Mem. Inst. Oswaldo Cruz 1999 Mar-Apr;94(2):167-72.
• 1999
  Gaubert S, Viana da Costa A, Maurage CA, Lima EC, Fontaine J, Lafitte S, Minoprio P, Capron A, Grzych JM, X-linked immunodeficiency affects the outcome of Schistosoma mansoni infection in the murine model, Parasite Immunol. 1999 Feb;21(2):89-101.
• 1998
  Da Silva AC, Espinoza AG, Taibi A, Ouaissi A, Minoprio P, A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator, Immunology 1998 Jun;94(2):189-96.
• 1997
  Lima EC, Garcia I, Vicentelli MH, Vassalli P, Minoprio P, Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice, Infect. Immun. 1997 Feb;65(2):457-65.
• 1996
  Cordeiro da Silva A, Lima EC, Vicentelli MH, Minoprio P, V beta 6-bearing T cells are involved in resistance to Trypanosoma cruzi infection in XID mice, Int. Immunol. 1996 Aug;8(8):1213-9.
• 1996
  Jungmann P, Freitas A, Bandeira A, Nobrega A, Coutinho A, Marcos MA, Minoprio P, Murine acariasis. II. Immunological dysfunction and evidence for chronic activation of Th-2 lymphocytes, Scand. J. Immunol. 1996 Jun;43(6):604-12.
• 1996
  Russo M, Starobinas N, Marcondes MC, Minoprio P, Honteyberie-Joskowicz M, The influence of T cell subsets on Trypanosoma cruzi multiplication in different organs, Immunol. Lett. 1996 Mar;49(3):163-8.
• 1996
  D'Império Lima MR, Alvarez JM, Furtado GC, Kipnis TL, Coutinho A, Minóprio P, Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells, Scand. J. Immunol. 1996 Mar;43(3):263-70.
• 1996
  Gueirard P, Minoprio P, Guiso N, Intranasal inoculation of Bordetella bronchiseptica in mice induces long-lasting antibody and T-cell mediated immune responses, Scand. J. Immunol. 1996 Feb;43(2):181-92.
• 1996
  Santos Lima EC, Minoprio P, Chagas’ disease is attenuated in mice lacking gamma delta T cells, Infect. Immun. 1996 Jan;64(1):215-21.
• 1995
  Castro AG, Minóprio P, Appelberg R, The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice, Immunology 1995 Aug;85(4):556-61.
• 1995
  Sato MN, Minoprio P, Avrameas S, Ternynck T, Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis, Immunology 1995 May;85(1):26-32.
• 1995
  Castro AG, Silva RA, Minóprio P, Appelberg R, In vivo evidence for a non-T cell origin of interleukin-5, Scand. J. Immunol. 1995 Mar;41(3):288-92.
• 1994
  Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minóprio P, Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection, Infect. Immun. 1994 Sep;62(9):3962-71.
• 1994
  Eckwalanga M, Marussig M, Tavares MD, Bouanga JC, Hulier E, Pavlovitch JH, Minoprio P, Portnoï D, Rénia L, Mazier D, Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology, Proc. Natl. Acad. Sci. U.S.A. 1994 Aug;91(17):8097-101.
• 1994
  Appelberg R, Castro AG, Pedrosa J, Minóprio P, Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice, Immunology 1994 Jul;82(3):361-4.
• 1994
  el-Cheikh MC, Dutra HS, Minóprio P, Borojevic R, Increase of B-lymphocyte number and activity during experimental murine schistosomiasis mansoni, Braz. J. Med. Biol. Res. 1994 Jul;27(7):1605-17.
• 1994
  Leite-de-Moraes MC, Coutinho A, Hontebeyrie-Joskowicz M, Minoprio P, Eisen H, Bandeira A, Skewed V beta TCR repertoire of CD8+ T cells in murine Trypanosoma cruzi infection, Int. Immunol. 1994 Mar;6(3):387-92.
• 1994
  Leite de Moraes MD, Minoprio P, Dy M, Dardenne M, Savino W, Hontebeyrie-Joskowicz M, Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi, Scand. J. Immunol. 1994 Jan;39(1):51-8.
• 1993
  Minoprio P, el Cheikh MC, Murphy E, Hontebeyrie-Joskowicz M, Coffman R, Coutinho A, O'Garra A, Xid-associated resistance to experimental Chagas’ disease is IFN-gamma dependent, J. Immunol. 1993 Oct;151(8):4200-8.
• 1992
  el Cheikh MC, Hontebeyrie-Joskowicz M, Coutinho A, Minoprio P, CD5 B cells. Potential role in the (auto)immune responses to Trypanosoma cruzi infection, Ann. N. Y. Acad. Sci. 1992 May;651:557-63.
• 1992
  Arala-Chaves M, Lima MR, Coutinho A, Pena-Rossi C, Minoprio P, V-region-related and -unrelated immunosuppression accompanying infections, Mem. Inst. Oswaldo Cruz 1992;87 Suppl 5:35-41.
• 1991
  Minoprio P, Coutinho A, Spinella S, Hontebeyrie-Joskowicz M, Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas’ disease, Int. Immunol. 1991 May;3(5):427-33.
• 1991
  Hontebeyrie-Joskowicz M, Minoprio P, Chagas’ disease: Trypanosoma cruzi vs. the host immune system, Res. Immunol. 1991 Feb;142(2):125-6.
• 1991
  Starobinas N, Russo M, Minoprio P, Hontebeyrie-Joskowicz M, Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice?, Res. Immunol. 1991 Feb;142(2):117-22.
• 1991
  Minoprio P, Chagas’ disease: CD5 B-cell-dependent Th2 pathology?, Res. Immunol. 1991 Feb;142(2):137-40.
• 1989
  Minoprio P, Itohara S, Heusser C, Tonegawa S, Coutinho A, Immunobiology of murine T. cruzi infection: the predominance of parasite-nonspecific responses and the activation of TCRI T cells, Immunol. Rev. 1989 Dec;112:183-207.
• 1989
  Aida Y, Miyasaka M, Okada K, Onuma M, Kogure S, Suzuki M, Minoprio P, Levy D, Ikawa Y, Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep, Am. J. Vet. Res. 1989 Nov;50(11):1946-51.
• 1989
  Russo M, Starobinas N, Ribeiro-Dos-Santos R, Minoprio P, Eisen H, Hontebeyrie-Joskowicz M, Susceptible mice present higher macrophage activation than resistant mice during infections with myotropic strains of Trypanosoma cruzi, Parasite Immunol. 1989 Jul;11(4):385-95.
• 1989
  Minoprio P, Andrade L, Lembezat MP, Ozaki LS, Coutinho A, Indiscriminate representation of VH-gene families in the murine B lymphocyte responses to Trypanosoma cruzi, J. Immunol. 1989 Jun;142(11):4017-21.
• 1989
  Minoprio P, Bandeira A, Pereira P, Mota Santos T, Coutinho A, Preferential expansion of Ly-1 B and CD4- CD8- T cells in the polyclonal lymphocyte responses to murine T. cruzi infection, Int. Immunol. 1989;1(2):176-84.
• 1988
  Minoprio P, Burlen O, Pereira P, Guilbert B, Andrade L, Hontebeyrie-Joskowicz M, Coutinho A, Most B cells in acute Trypanosoma cruzi infection lack parasite specificity, Scand. J. Immunol. 1988 Nov;28(5):553-61.
• 1988
  Minoprio P, Coutinho A, Lymphocyte subpopulations and clonal repertoires participate in immune response to acute T. cruzi infection, Mem. Inst. Oswaldo Cruz 1988 Nov;83 Suppl 1:356-9.
• 1988
  Russo M, Minoprio P, Coutinho A, Hontebeyrie-Joskowicz M, Depletion of L3T4+ T lymphocytes during acute Trypanosoma cruzi infection abolish macrophage and B lymphocyte activation but not tissue inflammatory reaction, Mem. Inst. Oswaldo Cruz 1988 Nov;83 Suppl 1:527-38.
• 1988
  Russo M, Starobinas N, Minoprio P, Coutinho A, Hontebeyrie-Joskowicz M, Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of helper T cells, Ann. Inst. Pasteur Immunol. 1988 May-Jun;139(3):225-36.
• 1987
  Minoprio P, Eisen H, Joskowicz M, Pereira P, Coutinho A, Suppression of polyclonal antibody production in Trypanosoma cruzi-infected mice by treatment with anti-L3T4 antibodies, J. Immunol. 1987 Jul;139(2):545-50.
• 1986
  Minoprio PM, Coutinho A, Joskowicz M, D'Imperio Lima MR, Eisen H, Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes, Scand. J. Immunol. 1986 Dec;24(6):669-79.
• 1986
  Minoprio PM, Eisen H, Forni L, D'Imperio Lima MR, Joskowicz M, Coutinho A, Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses, Scand. J. Immunol. 1986 Dec;24(6):661-8.
• 1986
  d'Imperio Lima MR, Eisen H, Minoprio P, Joskowicz M, Coutinho A, Persistence of polyclonal B cell activation with undetectable parasitemia in late stages of experimental Chagas’ disease, J. Immunol. 1986 Jul;137(1):353-6.
• 1980
  Capron M, Carlier Y, Nzeyimana H, Minoprio P, Santoro F, Sellin B, Capron A, In vitro study of immunological events in human and experimental schistosomiasis: relationships between cytotoxic antibodies and circulating Schistosoma antigens, Parasite Immunol. 1980;2(3):223-35.